Welcome : Guest

HTG Molecular Diagnostics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about HTG Molecular Diagnostics, Inc., which is principally involved in providing Instruments and Reagents for Molecular Profiling Applications. Illustrated with 88 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64592
Price: $3500
Company Type: Public
Pages: 96
Date: November 2016
Market Data Tables: 88

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: HTG Molecular Diagnostics, Inc.'s Revenues by Category (2014-2015) in Percentage for Product (HTG Edge, and HTG EdgeSeq Systems), Service, and Others......5
Diagnostic Testing......9
Table 2: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others......9
Table 3: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others......10
Table 4: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......11
Table 5: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......12
Table 6: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......13
Table 7: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......14
Table 8: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......15
Table 9: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......16
DNA Carrier Testing......17
Table 10: DNA Carrier Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......17
DNA & Gene Chips (Microarray)......18
Table 11: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......18
Table 12: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......19
Table 13: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......20
In Vitro Diagnostics (IVD)......21
Table 14: Global IVD Market (2014) in US$ Million......21
Table 15: In-Vitro Diagnostics (IVD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry, Hematology and Coagulation, Histology and Cytology, Immunoassays, Molecular Diagnostics, Point of Care and Others......22
Table 16: Global In Vitro Diagnostics (IVD) Market by Area (2015) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......23
Table 17: In Vitro Diagnostics (IVD) Market by Disease Type Worldwide (2015) - Percentage Breakdown by Value for Cancers, Cardio-Vascular Diseases, Infective Diseases, and Others......24
Table 18: In Vitro Diagnostics (IVD) Market by Product Category Worldwide (2015) - Percentage Breakdown by Value for Instrumentation, and Reagents......25
Table 19: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others......26
Table 20: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others......27
Table 21: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others......28
Table 22: In-Vitro Diagnostics (IVD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, United States and Others......29
Table 23: In-Vitro Diagnostics Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry Product, Hematology/Coagulation, Immunoassay Systems and others......30
Table 24: In-Vitro Diagnostic Products Market by Segment in China (2015) - Percentage Share Breakdown by Value for Blood Testing, Cellular Analysis, Clinical Chemistry, Diabetes Testing, Immunoassay, Microbiology, Molecular Diagnostics, and Pathology......31
Table 25: In Vitro Diagnostics (IVD) Market by Region in Europe (2015) - Percentage Share Breakdown by Value Sales for Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Switzerland, UK, and Rest of Europe......32
Table 26: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2015) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents......33
Table 27: In Vitro Diagnostics (IVD) Market by Category in France (2015) - Percentage Share Breakdown by Value Sales for Laboratory in Vitro Diagnostics, and Self-Monitoring of Blood Glucose......34
Molecular Diagnostics......35
Table 28: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......35
Table 29: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......36
Table 30: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......37
Table 31: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......38
Table 32: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......39
Table 33: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......40
Table 34: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......41
Table 35: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......42
Table 36: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......43
Table 37: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......44
Table 38: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......45
Table 39: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......46
Table 40: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......47
Table 41: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......48
Table 42: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......49
Table 43: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......50
Table 44: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......51
Table 45: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......52
Table 46: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......53
Table 47: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......54
Genetic Testing......55
Table 48: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......55
Table 49: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......56
Table 50: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......57
Genomic Technology......58
Table 51: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......58
Table 52: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......59
Table 53: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......60
Table 54: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......61
Table 55: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......62
Genomic Tools......63
Table 56: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......63
Genomics 2.0......64
Table 57: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......64
Table 58: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......65
Table 59: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......66
Table 60: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......67
Table 61: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......68
Table 62: Genomics 2.0 for Forensics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......69
Table 63: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......70
Table 64: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......71
Table 65: Genomics 2.0 for Livestock and Agriculture Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......72
Table 66: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......73
Table 67: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......74
Table 68: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......75
Table 69: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......76
Table 70: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......77
Table 71: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......78
Next-Generation Sequencing (NGS)......79
Table 72: Next-Generation Sequencing (NGS) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Library Preparation and Other Sample Preparations......79
Table 73: Global NGS Applications (2015) - Percentage Breakdown of Usage Share by End-Uses - Human Genome Research; Clinical Service Providers; Microorganisms, Plant and Animal Genetic Analysis and Molecular Diagnostics......80
Table 74: NGS Sequencing Market in North America (2014) - Percentage Share Breakdown by leading Players - Illumina/Solexa; Life Technologies, Roche/454, and Helicos......81
Table 75: Next Generation Sequencing Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Exome, Targeted Panels, Whole Genome, and Others......82
Clinical Diagnostics......83
Table 76: Clinical Diagnostics Market by Category in the US (2015) - Percentage Share Breakdown by Value for Hospital-Based Labs, Independent Clinical Labs, Labcorp, Physician-Office Labs, and Quest......83
Diagnostic Testing......84
Table 77: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......84
In Vitro Diagnostics (IVD)......85
Table 78: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others......85
Table 79: Market Shares of Leading In Vitro Diagnostics (IVD) Instrumentation (Mid to High throughput Analyzer) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Hitachi, Ltd., Invetech, KMC Systems Inc., Stratec Biomedical AG, Tecan Group Ltd., and Others......86
Table 80: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others......87
Table 81: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific, Inc., and Others......88
Table 82: Market Shares of Leading In-Vitro Diagnostics (IVD) Product Developers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Beckman Coulter, Inc., Johnson & Johnson, Roche Molecular Systems, Inc., Siemens AG and Others......89
Table 83: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others......90
Table 84: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......91
Molecular Diagnostics......92
Table 85: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......92
Table 86: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......93
Table 87: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......94
Genomics 2.0......95
Table 88: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......95